SRL
LABD icon

Scientech Research LLC’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Scientech Research LLC’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,180
Closed -$290K – 665
2025
Q3 		$290K Buy
+7,180
New +$416K 0.1% 387
2024
Q3 		– Sell
-1,819
Closed -$133K – 734
2024
Q2 		$133K Sell
1,819
-4,342
-70% -$366K 0.03% 542
2024
Q1 		$449K Buy
+6,161
New +$514K 0.24% 187

Other funds holding LABD

JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Scientech Research LLC's LABD Position: Q4 2025 in Review

Scientech Research LLC sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q4 2025, closing a stake of 7,180 shares — an estimated $290K sold.

Scientech Research LLC first reported a position in LABD in Q1 2024 and held it in 3 quarters. The position peaked at $449K in Q1 2024. 17 funds tracked by Wall St. Rank hold LABD as of Q4 2025.

  • Scientech Research LLC reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q4 2025 after selling out during the quarter.
  • Scientech Research LLC sold 7,180 Direxion Daily S&P Biotech Bear 3X ETF shares in Q4 2025, an estimated $290K.
  • Scientech Research LLC first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2024 and held it in 3 quarters.
  • Scientech Research LLC's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $449K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.